InSilico Medicine Cayman TopCo (O15)
Market Open
11 Aug, 13:26
XFRA XFRA Primary €
5. 25
0
0%
€
2.56B Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 5.25
Previous Close Want to track O15 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
InSilico Medicine Cayman TopCo (O15) Statistics
Valuation metrics
Market Cap 2.56B
Enterprise value 1.64B
Trailing P/E (ttm) -1
Forward P/E -
PEG ratio -
Price/Sales (ttm) 43.77
Price/Book (mrq) 6.26
Enterprise Value/Revenue 33.98
Enterprise Value/EBITDA -33.36
Overview
Shares outstanding 557.42M
Float 438.83M
Shares short -
% Held by insiders 0.33%
% Held by institutions 0.53%
Average volume (10 days) 350
Average volume (90 days) 450
Price summary
52-Week low 3.58
52-Week high 9
Beta -
50-Day moving average 6.36
200-Day moving average 6.53
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.82%
Operating margin -1.31%
Operational effectiveness
Return on assets -0.12%
Return on equity -0.78%
Income Statement
Revenue (ttm) 48.28M
Revenue per share (ttm) 0.71
Quarterly revenue growth (yoy) 0.1%
Gross profit (ttm) 39.36M
EBITDA -49.18M
Net income to common (ttm) -302.47M
Diluted EPS (ttm) -3.85
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 383.99M
Total cash per share (mrq) 0.8
Total debt (mrq) 5.12M
Total Debt/Equity (mrq) 1.32
Current ratio (mrq) 13.99%
Book value per share (mrq) 0.69
Cash Flow
Cash flow statement -65.91M
Levered free cash flow (LFCF) -704.45M
